Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000178555 | SCV000230658 | uncertain significance | not provided | 2015-01-09 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001086580 | SCV000289081 | benign | Long QT syndrome | 2023-12-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV000617636 | SCV000735889 | likely benign | Cardiovascular phenotype | 2015-09-16 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625230 | SCV000744224 | likely benign | Long QT syndrome 11 | 2017-06-28 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001260416 | SCV001437407 | benign | not specified | 2020-09-06 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000178555 | SCV001827990 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000178555 | SCV004164298 | likely benign | not provided | 2023-02-01 | criteria provided, single submitter | clinical testing | AKAP9: BP4, BP7 |
Clinical Genetics, |
RCV001260416 | SCV001919364 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000178555 | SCV001954441 | likely benign | not provided | no assertion criteria provided | clinical testing |